Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2018-08-21 | 2018-11-08 | 58634 |
| ACT EXEMESTANE | 25MG | TABLET | Resolved | 2018-12-04 | 2019-03-14 | 68592 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-02-05 | 2019-03-12 | 74792 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-06-03 | 2019-08-07 | 85468 |
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Actual shortage | 2019-06-27 | 2019-08-07 | 87673 |
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Actual shortage | 2019-06-27 | 2019-08-07 | 87676 |
| TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2019-07-02 | 2020-08-21 | 88195 |
| TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2019-07-02 | 2020-04-23 | 88198 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-08-06 | 2019-11-19 | 90935 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-09-05 | 2020-09-18 | 93166 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-09-19 | 2020-07-10 | 94384 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-10-10 | 2020-03-05 | 96079 |
| TEVA-CAPTOPRIL | 25MG | TABLET | Resolved | 2019-10-31 | 2020-01-09 | 97611 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-11-21 | 2020-01-09 | 99441 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Avoided shortage | 2019-11-21 | 2020-07-10 | 99453 |
| TEVA-METOPROLOL | 25MG | TABLET | Resolved | 2019-12-05 | 2021-09-30 | 100308 |
| TEVA-ATENOLOL | 25MG | TABLET | Actual shortage | 2020-01-24 | 2020-01-24 | 104310 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-03-06 | 2020-03-26 | 107970 |
| TEVA-CARVEDILOL | 25MG | TABLET | Resolved | 2020-03-12 | 2020-03-26 | 108593 |
| TEVA-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2020-03-26 | 2021-04-15 | 109632 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 |